Analyze Diet
Stem cell research & therapy2020; 11(1); 152; doi: 10.1186/s13287-020-01640-8

Multi-differentiation potential is necessary for optimal tenogenesis of tendon stem cells.

Abstract: Tendon injury is a significant clinical problem due to poor healing and a high reinjury rate; successful treatment is limited by our poor understanding of endogenous tendon stem cells. Recent evidence suggests that adult stem cells are phenotypically diverse, even when comparing stem cells isolated from the same tissue from the same individual, and may in fact exist on a spectrum of proliferation and differentiation capacities. Additionally, the relationships between and clinical relevance of this phenotypic variation are poorly understood. In particular, tenogenic capacity has not been studied in comparison to tenogenic differentiation and cell proliferation. Toward this end, we performed a comprehensive assessment of cell proliferation and differentiation capacity toward four connective tissue lineages (tendon, cartilage, bone, and adipose) using tendon stem cell lines derived from single cells released directly from tendon tissue to (1) evaluate the differences, if any, in tenogenic potential, and (2) identify the relationships between differentiation phenotypes and proliferation capacity. Tendon stem cells were derived from the endotenon of superficial digital flexor tendon from 3 horses. The cell suspension from each horse was separately plated simultaneously (1) at moderate density to generate a heterogenous population of cells-parent tendon cell line-and (2) at low density to separate single cells from each other to allow isolation of colonies that derive from single mother cells-clonal tendon stem cell lines. Thirty clonal tendon stem cell lines-10 from each horse-and each parent tendon cell line were assessed for tenogenesis, tri-lineage differentiation, and cell proliferation. Differentiation was confirmed by lineage-specific cell staining and quantified by the relative gene expression of lineage-specific markers. Statistical significance was determined using analysis of variance and post hoc Tukey's tests. Three distinct differentiation phenotypes-differentiation potency toward all 4 tissue lineages and two tri-lineage differentiation potencies-were identified in tendon clonal stem cell lines. These phenotypes were differentiation toward (1) tendon, cartilage, bone, and adipose (TCOA); (2) tendon, cartilage, and bone (TCO); and (3) tendon, cartilage, and adipose (TCA). Further, clonal cell lines that differentiated toward all four lineages had the highest expression of scleraxis and mohawk upon tenogenesis. Moreover, cell proliferation was significantly different between phenotypic groups, as evidenced by increased numbers of cumulative cell population doublings in clonal cell lines that did not differentiate toward adipose. Our study provides evidence of the heterogenous character of adult stem cells and identifies key differences in tendon stem cell differentiation and proliferative potentials from the same individual and from the same tendon. Isolation of tendon stem cell lines with the capacity to differentiate into all four connective tissue lineages may yield improved therapeutic benefits in clinical models of repair and promote a native, regenerative phenotype in engineered tendons. Future studies may be targeted to understanding the functional contributions of each tendon stem cell phenotype in vivo and identifying additional cell phenotypes.
Publication Date: 2020-04-09 PubMed ID: 32272975PubMed Central: PMC7146987DOI: 10.1186/s13287-020-01640-8Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research investigates the diverse abilities of tendon stem cells to differentiate into the four main connective tissue types – tendon, cartilage, bone, and adipose tissue – and how this potential can be harnessed to better treat tendon injuries, which are currently difficult to manage due to poor healing and high reinjury rates.

Study Design and Methodology

  • Tendon stem cells were harvested from the superficial digital flexor tendon of three horses. Each sample was plated at both moderate and low densities to generate a mixed community of cells and single-cell colonies respectively.
  • These cellular lines, a total of thirty distinct stem cell lines from each horse plus the parent cells, were then tested for their potential to differentiate into the four main connective tissue lineages.
  • Lineage-specific staining and gene expression analysis were used to confirm differentiation into each type of tissue.

Findings

  • The results demonstrated three distinct phenotypes signifying the different differentiation potentials. The first group could differentiate into all four tissue types (tendon, cartilage, bone, and adipose). The second group exhibited tri-lineage differentiation towards tendon, cartilage, and bone. The third group showed a tendency to differentiate into tendon, cartilage, and adipose.
  • Cells which could differentiate into all four tissue types showed the highest expression of certain genes (scleraxis and mohawk) related to tendon creation.
  • Interestingly, the study found correlation between a cell’s differentiation potential and its proliferation capacity. Cell lines that did not differentiate into adipose tissue had significantly greater proliferation, indicating a link between differentiation ability and growth capacity.

Implication and Future Research

  • This study expanded the understanding of tendon stem cells’ differentiation ability and their variability. These findings could be critical to improving therapies for tendon injuries, potentially leading to better healing and decreased reinjury rates.
  • Isolating and utilizing tendon stem cells with multi-differentiation potentials may lead to improved tissue repair and promote a more natural healing response in tendon injuries.
  • Further research needs to investigate the role of each phenotype during tendon healing in vivo, possibly identifying additional phenotypes which could be used for specific therapeutic strategies.

Cite This Article

APA
Rajpar I, Barrett JG. (2020). Multi-differentiation potential is necessary for optimal tenogenesis of tendon stem cells. Stem Cell Res Ther, 11(1), 152. https://doi.org/10.1186/s13287-020-01640-8

Publication

ISSN: 1757-6512
NlmUniqueID: 101527581
Country: England
Language: English
Volume: 11
Issue: 1
Pages: 152
PII: 152

Researcher Affiliations

Rajpar, Ibtesam
  • Department of Large Animal Clinical Sciences, Marion duPont Scott Equine Medical Center, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, Leesburg, 17690 Old Waterford Road, Leesburg, VA, 20176, USA.
Barrett, Jennifer G
  • Department of Large Animal Clinical Sciences, Marion duPont Scott Equine Medical Center, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, Leesburg, 17690 Old Waterford Road, Leesburg, VA, 20176, USA. jgbarrett@vt.edu.

MeSH Terms

  • Adipose Tissue
  • Animals
  • Cell Differentiation
  • Horses
  • Mesenchymal Stem Cells
  • Stem Cells
  • Tendons
  • Tissue Engineering

Conflict of Interest Statement

The authors declare that they have no competing interests.

References

This article includes 43 references
  1. Butler DL, Juncosa-Melvin N, Boivin GP, Galloway MT, Shearn JT, Gooch C, Awad H. Functional tissue engineering for tendon repair: A multidisciplinary strategy using mesenchymal stem cells, bioscaffolds, and mechanical stimulation.. J Orthop Res 2008 Jan;26(1):1-9.
    doi: 10.1002/jor.20456pubmed: 17676628google scholar: lookup
  2. Järvinen TA, Kannus P, Paavola M, Järvinen TL, Józsa L, Järvinen M. Achilles tendon injuries.. Curr Opin Rheumatol 2001 Mar;13(2):150-5.
  3. Itoi E. Rotator cuff tear: physical examination and conservative treatment.. J Orthop Sci 2013 Mar;18(2):197-204.
    doi: 10.1007/s00776-012-0345-2pmc: PMC3607722pubmed: 23306597google scholar: lookup
  4. Tang JB, Wu YF, Cao Y, Chen CH, Zhou YL, Avanessian B, Shimada M, Wang XT, Liu PY. Basic FGF or VEGF gene therapy corrects insufficiency in the intrinsic healing capacity of tendons.. Sci Rep 2016 Feb 11;6:20643.
    doi: 10.1038/srep20643pmc: PMC4749961pubmed: 26865366google scholar: lookup
  5. Akyol E, Hindocha S, Khan WS. Use of stem cells and growth factors in rotator cuff tendon repair.. Curr Stem Cell Res Ther 2015;10(1):5-10.
  6. Martinello T, Bronzini I, Perazzi A, Testoni S, De Benedictis GM, Negro A, Caporale G, Mascarello F, Iacopetti I, Patruno M. Effects of in vivo applications of peripheral blood-derived mesenchymal stromal cells (PB-MSCs) and platlet-rich plasma (PRP) on experimentally injured deep digital flexor tendons of sheep.. J Orthop Res 2013 Feb;31(2):306-14.
    doi: 10.1002/jor.22205pubmed: 22893604google scholar: lookup
  7. Godwin EE, Young NJ, Dudhia J, Beamish IC, Smith RK. Implantation of bone marrow-derived mesenchymal stem cells demonstrates improved outcome in horses with overstrain injury of the superficial digital flexor tendon.. Equine Vet J 2012 Jan;44(1):25-32.
  8. Mienaltowski MJ, Adams SM, Birk DE. Regional differences in stem cell/progenitor cell populations from the mouse achilles tendon.. Tissue Eng Part A 2013 Jan;19(1-2):199-210.
    doi: 10.1089/ten.tea.2012.0182pmc: PMC3530943pubmed: 22871316google scholar: lookup
  9. Bi Y, Ehirchiou D, Kilts TM, Inkson CA, Embree MC, Sonoyama W, Li L, Leet AI, Seo BM, Zhang L, Shi S, Young MF. Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their niche.. Nat Med 2007 Oct;13(10):1219-27.
    doi: 10.1038/nm1630pubmed: 17828274google scholar: lookup
  10. Kader D, Saxena A, Movin T, Maffulli N. Achilles tendinopathy: some aspects of basic science and clinical management.. Br J Sports Med 2002 Aug;36(4):239-49.
    doi: 10.1136/bjsm.36.4.239pmc: PMC1724537pubmed: 12145112google scholar: lookup
  11. Clegg PD, Strassburg S, Smith RK. Cell phenotypic variation in normal and damaged tendons.. Int J Exp Pathol 2007 Aug;88(4):227-35.
  12. Lui PP. Identity of tendon stem cells--how much do we know?. J Cell Mol Med 2013 Jan;17(1):55-64.
    doi: 10.1111/jcmm.12007pmc: PMC3823136pubmed: 23279609google scholar: lookup
  13. Cadby JA, Buehler E, Godbout C, van Weeren PR, Snedeker JG. Differences between the cell populations from the peritenon and the tendon core with regard to their potential implication in tendon repair.. PLoS One 2014;9(3):e92474.
  14. Song SU, Kim CS, Yoon SP, Kim SK, Lee MH, Kang JS, Choi GS, Moon SH, Choi MS, Cho YK, Son BK. Variations of clonal marrow stem cell lines established from human bone marrow in surface epitopes, differentiation potential, gene expression, and cytokine secretion.. Stem Cells Dev 2008 Jun;17(3):451-61.
    doi: 10.1089/scd.2007.0167pubmed: 18513161google scholar: lookup
  15. Chen J, Zhang W, Liu Z, Zhu T, Shen W, Ran J, Tang Q, Gong X, Backman LJ, Chen X, Chen X, Wen F, Ouyang H. Characterization and comparison of post-natal rat Achilles tendon-derived stem cells at different development stages.. Sci Rep 2016 Mar 14;6:22946.
    doi: 10.1038/srep22946pmc: PMC4789738pubmed: 26972579google scholar: lookup
  16. Kim M, Kim C, Choi YS, Kim M, Park C, Suh Y. Age-related alterations in mesenchymal stem cells related to shift in differentiation from osteogenic to adipogenic potential: implication to age-associated bone diseases and defects.. Mech Ageing Dev 2012 May;133(5):215-25.
    doi: 10.1016/j.mad.2012.03.014pubmed: 22738657google scholar: lookup
  17. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop Dj, Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.. Cytotherapy 2006;8(4):315-7.
    doi: 10.1080/14653240600855905pubmed: 16923606google scholar: lookup
  18. Whitfield MJ, Lee WC, Van Vliet KJ. Onset of heterogeneity in culture-expanded bone marrow stromal cells.. Stem Cell Res 2013 Nov;11(3):1365-77.
    doi: 10.1016/j.scr.2013.09.004pubmed: 24103495google scholar: lookup
  19. Rajpar I, Barrett JG. Optimizing growth factor induction of tenogenesis in three-dimensional culture of mesenchymal stem cells.. J Tissue Eng 2019 Jan-Dec;10:2041731419848776.
    doi: 10.1177/2041731419848776pmc: PMC6535701pubmed: 31205672google scholar: lookup
  20. Mathupala S, Sloan AA. An agarose-based cloning-ring anchoring method for isolation of viable cell clones.. Biotechniques 2009 Apr;46(4):305-7.
    doi: 10.2144/000113079pmc: PMC2727865pubmed: 19450237google scholar: lookup
  21. Sworder BJ, Yoshizawa S, Mishra PJ, Cherman N, Kuznetsov SA, Merlino G, Balakumaran A, Robey PG. Molecular profile of clonal strains of human skeletal stem/progenitor cells with different potencies.. Stem Cell Res 2015 May;14(3):297-306.
    doi: 10.1016/j.scr.2015.02.005pmc: PMC4439347pubmed: 25814434google scholar: lookup
  22. Liu ZQ. Scale space approach to directional analysis of images.. Appl Opt 1991 Apr 10;30(11):1369-73.
    doi: 10.1364/AO.30.001369pubmed: 20700292google scholar: lookup
  23. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.. Methods 2001 Dec;25(4):402-8.
    doi: 10.1006/meth.2001.1262pubmed: 11846609google scholar: lookup
  24. Lui PP. Markers for the identification of tendon-derived stem cells in vitro and tendon stem cells in situ - update and future development.. Stem Cell Res Ther 2015 Jun 2;6(1):106.
    doi: 10.1186/s13287-015-0097-ypmc: PMC4451873pubmed: 26031740google scholar: lookup
  25. Schweitzer R, Chyung JH, Murtaugh LC, Brent AE, Rosen V, Olson EN, Lassar A, Tabin CJ. Analysis of the tendon cell fate using Scleraxis, a specific marker for tendons and ligaments.. Development 2001 Oct;128(19):3855-66.
    pubmed: 11585810doi: 10.1242/dev.128.19.3855google scholar: lookup
  26. Bagchi RA, Czubryt MP. Scleraxis: a new regulator of extracellular matrix formation.. Genes and Cardiovascular Function Boston Springer; 2011. p. 57–65.
  27. Liu H, Zhang C, Zhu S, Lu P, Zhu T, Gong X, Zhang Z, Hu J, Yin Z, Heng BC, Chen X, Ouyang HW. Mohawk promotes the tenogenesis of mesenchymal stem cells through activation of the TGFβ signaling pathway.. Stem Cells 2015 Feb;33(2):443-55.
    doi: 10.1002/stem.1866pubmed: 25332192google scholar: lookup
  28. Brent AE, Schweitzer R, Tabin CJ. A somitic compartment of tendon progenitors.. Cell 2003 Apr 18;113(2):235-48.
    doi: 10.1016/S0092-8674(03)00268-Xpubmed: 12705871google scholar: lookup
  29. Ito Y, Toriuchi N, Yoshitaka T, Ueno-Kudoh H, Sato T, Yokoyama S, Nishida K, Akimoto T, Takahashi M, Miyaki S, Asahara H. The Mohawk homeobox gene is a critical regulator of tendon differentiation.. Proc Natl Acad Sci U S A 2010 Jun 8;107(23):10538-42.
    doi: 10.1073/pnas.1000525107pmc: PMC2890854pubmed: 20498044google scholar: lookup
  30. Kannus P. Structure of the tendon connective tissue.. Scand J Med Sci Sports 2000 Dec;10(6):312-20.
  31. Pingel J, Lu Y, Starborg T, Fredberg U, Langberg H, Nedergaard A, Weis M, Eyre D, Kjaer M, Kadler KE. 3-D ultrastructure and collagen composition of healthy and overloaded human tendon: evidence of tenocyte and matrix buckling.. J Anat 2014 May;224(5):548-55.
    doi: 10.1111/joa.12164pmc: PMC3981497pubmed: 24571576google scholar: lookup
  32. Lui PP, Chan LS, Lee YW, Fu SC, Chan KM. Sustained expression of proteoglycans and collagen type III/type I ratio in a calcified tendinopathy model.. Rheumatology (Oxford) 2010 Feb;49(2):231-9.
    doi: 10.1093/rheumatology/kep384pubmed: 19955224google scholar: lookup
  33. Zhang G, Ezura Y, Chervoneva I, Robinson PS, Beason DP, Carine ET, Soslowsky LJ, Iozzo RV, Birk DE. Decorin regulates assembly of collagen fibrils and acquisition of biomechanical properties during tendon development.. J Cell Biochem 2006 Aug 15;98(6):1436-49.
    doi: 10.1002/jcb.20776pubmed: 16518859google scholar: lookup
  34. Greinstein MMD, Rajagopal J, Galloway JL. Identification of a latent resident progenitor population in the adult mouse tendon.. Orthopaedic Research Society Annual Meeting Austin; 2019.
  35. Kishimoto Y, Ohkawara B, Sakai T, Ito M, Masuda A, Ishiguro N, Shukunami C, Docheva D, Ohno K. Wnt/β-catenin signaling suppresses expressions of Scx, Mkx, and Tnmd in tendon-derived cells.. PLoS One 2017;12(7):e0182051.
  36. Kuo CK, Tuan RS. Mechanoactive tenogenic differentiation of human mesenchymal stem cells.. Tissue Eng Part A 2008 Oct;14(10):1615-27.
    doi: 10.1089/ten.tea.2006.0415pubmed: 18759661google scholar: lookup
  37. Chen MY, Jeng L, Sun YL, Zhao CF, Zobitz ME, Moran SL, Amadio PC, An KN. Contraction of collagen gels seeded with tendon cells.. Biorheology 2006;43(3,4):337-45.
    pubmed: 16912406
  38. Torres DS, Freyman TM, Yannas IV, Spector M. Tendon cell contraction of collagen-GAG matrices in vitro: effect of cross-linking.. Biomaterials 2000 Aug;21(15):1607-19.
    doi: 10.1016/S0142-9612(00)00051-Xpubmed: 10885733google scholar: lookup
  39. Buckley MR, Sarver JJ, Freedman BR, Soslowsky LJ. The dynamics of collagen uncrimping and lateral contraction in tendon and the effect of ionic concentration.. J Biomech 2013 Sep 3;46(13):2242-9.
  40. Zhang X, Yang M, Lin L, Chen P, Ma KT, Zhou CY, Ao YF. Runx2 overexpression enhances osteoblastic differentiation and mineralization in adipose--derived stem cells in vitro and in vivo.. Calcif Tissue Int 2006 Sep;79(3):169-78.
    doi: 10.1007/s00223-006-0083-6pubmed: 16969589google scholar: lookup
  41. Russell KC, Phinney DG, Lacey MR, Barrilleaux BL, Meyertholen KE, O'Connor KC. In vitro high-capacity assay to quantify the clonal heterogeneity in trilineage potential of mesenchymal stem cells reveals a complex hierarchy of lineage commitment.. Stem Cells 2010 Apr;28(4):788-98.
    doi: 10.1002/stem.312pubmed: 20127798google scholar: lookup
  42. Muraglia A, Cancedda R, Quarto R. Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model.. J Cell Sci 2000 Apr;113 ( Pt 7):1161-6.
    pubmed: 10704367doi: 10.1242/jcs.113.7.1161google scholar: lookup
  43. Russell KC, Lacey MR, Gilliam JK, Tucker HA, Phinney DG, O'Connor KC. Clonal analysis of the proliferation potential of human bone marrow mesenchymal stem cells as a function of potency.. Biotechnol Bioeng 2011 Nov;108(11):2716-26.
    doi: 10.1002/bit.23193pmc: PMC3178709pubmed: 21538337google scholar: lookup

Citations

This article has been cited 12 times.
  1. Koch DW, Berglund AK, Messenger KM, Gilbertie JM, Ellis IM, Schnabel LV. Interleukin-1β in tendon injury enhances reparative gene and protein expression in mesenchymal stem cells. Front Vet Sci 2022;9:963759.
    doi: 10.3389/fvets.2022.963759pubmed: 36032300google scholar: lookup
  2. Ellis I, Schnabel LV, Berglund AK. Defining the Profile: Characterizing Cytokines in Tendon Injury to Improve Clinical Therapy. J Immunol Regen Med 2022 May;16.
    doi: 10.1016/j.regen.2022.100059pubmed: 35309714google scholar: lookup
  3. Rajpar I, Tomlinson RE. Function of peripheral nerves in the development and healing of tendon and bone. Semin Cell Dev Biol 2022 Mar;123:48-56.
    doi: 10.1016/j.semcdb.2021.05.001pubmed: 33994302google scholar: lookup
  4. Jayaraman P, Lim R, Ng J, Vemuri MC. Acceleration of Translational Mesenchymal Stromal Cell Therapy Through Consistent Quality GMP Manufacturing. Front Cell Dev Biol 2021;9:648472.
    doi: 10.3389/fcell.2021.648472pubmed: 33928083google scholar: lookup
  5. Huang Z, Yin Z, Xu J, Fei Y, Heng BC, Jiang X, Chen W, Shen W. Tendon Stem/Progenitor Cell Subpopulations and Their Implications in Tendon Biology. Front Cell Dev Biol 2021;9:631272.
    doi: 10.3389/fcell.2021.631272pubmed: 33681210google scholar: lookup
  6. Chen J, Wang Z, Yi M, Yang Y, Tian M, Liu Y, Wang G, Shen H. Regenerative properties of bone marrow mesenchymal stem cell derived exosomes in rotator cuff tears. J Transl Med 2025 Jan 12;23(1):47.
    doi: 10.1186/s12967-024-06029-2pubmed: 39800717google scholar: lookup
  7. Lin W, Lin Z, Wu L, Zheng Y, Xi H. NSUN2 facilitates tenogenic differentiation of rat tendon-derived stem cells via m5C methylation of KLF2. Regen Ther 2024 Jun;26:792-799.
    doi: 10.1016/j.reth.2024.08.023pubmed: 39309399google scholar: lookup
  8. He W, Jiang C, Zhou P, Hu X, Gu X, Zhang S. Role of tendon-derived stem cells in tendon and ligament repair: focus on tissue engineer. Front Bioeng Biotechnol 2024;12:1357696.
    doi: 10.3389/fbioe.2024.1357696pubmed: 39175617google scholar: lookup
  9. Li H, Li Y, Luo S, Zhang Y, Feng Z, Li S. The roles and mechanisms of the NF-κB signaling pathway in tendon disorders. Front Vet Sci 2024;11:1382239.
    doi: 10.3389/fvets.2024.1382239pubmed: 38978635google scholar: lookup
  10. Zhang Z, Zhang Y, Wang H, Li B, Cao R, Li Y, Cui S, Zhang W. Curcumin Improves Functional Recovery of Ruptured Tendon by Promoting Tenogenesis via PI3K/Akt Signaling. Stem Cells Transl Med 2024 May 14;13(5):477-489.
    doi: 10.1093/stcltm/szae007pubmed: 38387017google scholar: lookup
  11. Siu WS, Ma H, Ko CH, Shiu HT, Cheng W, Lee YW, Kot CH, Leung PC, Lui PPY. Rat Plantar Fascia Stem/Progenitor Cells Showed Lower Expression of Ligament Markers and Higher Pro-Inflammatory Cytokines after Intensive Mechanical Loading or Interleukin-1β Treatment In Vitro. Cells 2023 Sep 6;12(18).
    doi: 10.3390/cells12182222pubmed: 37759446google scholar: lookup
  12. Chen J, Jiang C, Yin L, Liu Y, He Y, Li S, Shen H. A Review of the Role of Tendon Stem Cells in Tendon-Bone Regeneration. Med Sci Monit 2023 Sep 16;29:e940805.
    doi: 10.12659/MSM.940805pubmed: 37715366google scholar: lookup